Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 147

Results For "AIM"

1755 News Found

Arctoris and Evariste Technologies form JV to treat non-small cell lung cancer
Biotech | March 07, 2022

Arctoris and Evariste Technologies form JV to treat non-small cell lung cancer

Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)


Lupin signs Mary Kom for its Shakti campaign promoting heart health
Healthcare | March 07, 2022

Lupin signs Mary Kom for its Shakti campaign promoting heart health

The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women


Healthium collaborates with Abhinav Bindra to treat sports injuries
Healthcare | March 06, 2022

Healthium collaborates with Abhinav Bindra to treat sports injuries

According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport


Evonik expands production of plant-derived cholesterol in Germany
News | March 06, 2022

Evonik expands production of plant-derived cholesterol in Germany

The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol


WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP
News | March 04, 2022

WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP

Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements


Known Medicine partners with Duke University to predict lung cancer response to drug treatments
Biotech | March 04, 2022

Known Medicine partners with Duke University to predict lung cancer response to drug treatments

Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer


AIkido Pharma improves manufacturing process for pancreatic drug
Biotech | March 04, 2022

AIkido Pharma improves manufacturing process for pancreatic drug

The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug


AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio
News | March 04, 2022

AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio

Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies


New CellScape system for high-plex and high-throughput targeted spatial proteomics
Medical Device | March 04, 2022

New CellScape system for high-plex and high-throughput targeted spatial proteomics

ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumour microenvironment, as well as deep immune profiling for applications in immunology, neuroscience, and infectious disease


Aster Labs expands across south and west India
Clinical Trials | March 04, 2022

Aster Labs expands across south and west India

A total of 17 labs will be operational across the country by this month